Innate Pharma to share new long-term data on Lumoxiti at 2019 American Society of Hematology annual meeting
Innate Pharma S.A. - American Depositary Shares (IPHA)
Company Research
Source: GlobeNewswire
Long-term data analysis will expand on previously reported efficacy results from Lumoxiti Phase III trial Marseille, France, November 7, 2019, 7:00 AM CET Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) will share new, long-term data from the pivotal Phase III trial of Lumoxiti® (moxetumomab pasudotox) at the 61st American Society of Hematology (ASH) Annual Meeting in Orlando, Florida, December 7-10. “At this year’s ASH, we look forward to providing important new follow-up data from the Lumoxiti phase III trial and engaging with the hemato-oncology community on improving treatment outcomes for patients with relapsed or refractory hairy cell leukemia,” commented Pierre Dodion, MD, Executive Vice President and Chief Medical Officer of Innate Pharma. Details of the poster presentation at ASH are as follows: ·Moxetumomab Pasudotox-tdfk in Heavily Pretreated Patients with Relapsed/Refractory Hairy Cell Leukemia (HCL): Lon
Show less
Read more
Impact Snapshot
Event Time:
IPHA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IPHA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IPHA alerts
High impacting Innate Pharma S.A. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IPHA
News
- Innate Pharma Announces Its Participation in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Innate Pharma Announces Its Participation in Upcoming Investor ConferencesBusiness Wire
- Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual MeetingBusiness Wire
- Outcome of Innate Pharma’s 2024 Annual General MeetingBusiness Wire
- Innate Pharma: Clarification Regarding SAR443579 DesignationBusiness Wire